Brief report · 30 Jan 2025
Conference abstractPublished 30 Mar 2021
NEUROPHYSIOLOGY 2021: Therapeutic effect of novel antidepressant drugs interfering with receptors of neurotransmitters and neuropeptides- Euro Akademie Pobneck, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Major depression is a frequent psychiatric disease, which is mainly treated by different antidepressant drugs. However, one third of the depressive patients remain treatment-resistant. In major depression, in the brainstem, hippocampus and prefrontal cortex, alterations of neurotransmitters and neuropeptides and the belonging neural networks are updated. Starting from these findings, novel antidepressant drugs and combination of different antidepressant drugs are suggested. In the prefrontal cortex, glutamatergic neurons, which receive a postsynaptic excitatory potential from D2 dopaminergic neurons, exert a presynaptic inhibition upon M1 muscarinic cholinergic neurons via NMDA receptors. Medium spiny GABAergic/somatostatin neurons
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Cognitive Neuropsychology.
Opinion · 30 Jan 2025
Cognitive Neuropsychology of Reading and Dyslexia: Brain–behavior Correlates
Commentary · 30 Jan 2025
The Role of the Prefrontal Cortex in Executive Dysfunction: A Cognitive Neuropsychology Approach
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cognitive Neuropsychology
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Felix-Martin Werner”
